CSIMarket


Forte Biosciences Inc   (NASDAQ: FBRX)
Other Ticker:  
 

Forte Biosciences Inc

FBRX's Fundamental analysis








Forte Biosciences Inc 's sales fell in the second quarter of 2025 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded growth of revenues by 8.14 %

Forte Biosciences Inc net loss decreased from $-13 millions, to $-11 millions in second quarter of 2025,

More on FBRX's Growth


Forte Biosciences Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 1.69 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.86.


More on FBRX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 8.42

Forte Biosciences Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 1.69 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.86.

Forte Biosciences Inc Price to Book Ratio is at 1.4 lower than Industry Avg. of 105.06. and higher than S&P 500 Avg. of 0.02

More on FBRX's Valuation

  Market Capitalization (Millions $) 138
  Shares Outstanding (Millions) 12
  Employees 14
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -42
  Cash Flow (TTM) (Millions $) 82
  Capital Exp. (TTM) (Millions $) -
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) 8.42

  Market Capitalization (Millions $) 138
  Shares Outstanding (Millions) 12
  Employees 14
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -42
  Cash Flow (TTM) (Millions $) 82
  Capital Exp. (TTM) (Millions $) -





  Ratio
   Capital Ratio (MRQ) 11.74
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.09
  Asset Turnover Ratio (TTM) -
  Inventory Turnover Ratio (TTM) -





Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.